Medicine
Follow Medicine in the Factlen app and get an alert when there is news. Get the app
- All Health
- Nutrition & Diet
- Supplements
- Mental Health
- Sleep
- Longevity
- Medicine
- Medications & Treatments
- Conditions & Diseases
- Hormones & Endocrinology
- Skincare
- Dental Health
- Family Health
- Children's Health
- Men's Health
- Women's Health
- Aging & Geroscience
- Biohacking
- Alternative Medicine
- Public Health
- Medical Research
- Preventive Wellness
- Healthy Habits
Deep Dive
The 'Ozempic Effect': Comparing the Retail Impact on Apparel, Food, and Wellness Sales
5 sources · 56d ago
Oral GLP-1s
FDA Approves Eli Lilly's Foundayo, Second Oral GLP-1 Tablet, Intensifying Weight-Loss Drug Competition
7 sources · 58d ago
Autoimmune Therapy
Novel Oral TYK2 Inhibitors Achieve Simultaneous Phase 3 Success for Atopic Dermatitis and Psoriasis
5 sources · 59d ago
More in Medicine
Research BriefBipolar Disorder
Landmark Review Identifies Best Drug and Non-Drug Treatments for Bipolar Disorder Across All Mood Phases
Clinical Researchers 40%Patient Advocates 35%Pediatric Specialists 25%
ExplainerGLP-1 Research
Ozempic Works by Unexpectedly Activating Brain's Hunger Neurons to Sustain Fat Loss
Metabolic Researchers 40%Science Communicators 30%Clinical Analysts 30%
NeuroimmunologyBreakthrough Discovery
Newly Discovered 'Immune Organ' Inside Skull Directs Brain Defense, Rewriting Neuroimmunology
Neuroimmunologists 40%Oncology Researchers 35%Clinical Neurologists 25%
ExplainerSchizophrenia Treatment
FDA Approves Cobenfy, First Non-Dopamine Antipsychotic for Schizophrenia
Psychiatric Clinicians 40%Regulatory & Clinical Researchers 35%Patient Advocacy & Caregivers 25%
ExplainerObesity Medicine
Triple-Agonist Retatrutide Achieves 30% Weight Loss in Trials, Matching Bariatric Surgery Efficacy
Pharmacotherapy Advocates 45%Surgical Specialists 30%Patient Advocates 25%
ExplainerLymphoma Treatment
FDA-Approved Cancer Drug Epcoritamab Misses Overall Survival Endpoint in Confirmatory Phase 3 Trial
Regulatory Watchdogs 35%Clinical Oncologists 35%Drug Developers 30%
GLP-1 TherapyTreatment Comparison
FDA Approves Orforglipron, the First Restriction-Free Daily GLP-1 Pill for Weight Loss
Accessibility & Convenience Advocates 45%Maximum Efficacy Prioritizers 35%Clinical Safety Watchdogs 20%
ExplainerOncology Research
Lab-Made Molecule Wipes Out Aggressive Breast and Pancreatic Tumors in Preclinical Trials
Immunotherapy Researchers 40%Translational Oncologists 35%Drug Development Chemists 25%
Psoriasis TreatmentFDA Approval
FDA Approves Icotrokinra, First Oral Peptide With Biologic-Like Efficacy for Psoriasis
Clinical Dermatologists 45%Pharmaceutical Industry 30%Pharmacy and Managed Care 25%
Genetic MedicineTreatment Explainer
FDA Approves First Gene Therapy for Congenital Deafness, Restoring Hearing in Children
Clinical Audiologists & ENTs 45%Deaf Community Advocates 30%Medical Geneticists 25%
ExplainerMedical AI
How AI Models Are Matching Physicians in Clinical Reasoning
Clinical AI Researchers 40%Practicing Physicians 35%Patient Safety Advocates 25%
ExplainerPain Pharmacology
Can a New, Safer Class of Pain Drugs Ever Rival Opioids?
Pharmacologists & Chemists 35%Clinical Pain Specialists 35%Public Health Advocates 30%
ExplainerAddiction Medicine
Landmark Study Links GLP-1 Drugs to Reduced Risk of Alcohol, Opioid, and Nicotine Addiction
Addiction Medicine Researchers 40%Public Health Officials 35%Clinical Skeptics 25%
AnalysisObesity Therapeutics
New Oral GLP-1 Pill Achieves 12% Weight Loss in Phase II Trial, Offering Scalable Alternative to Injectables
Clinical Researchers 40%Biotech Industry Analysts 40%Patient Access Advocates 20%
Vaccine TechMedical Milestone
Fridge-Free Tetanus-Diphtheria Vaccine Passes First Human Trial, Solving Global Cold-Chain Crisis
Global Health Advocates 40%Scientific Skeptics 30%Biotech Industry 30%
ExplainerBreast Cancer
Blood Biomarker Predicts Chemotherapy Benefit in Breast Cancer, Sparing Thousands of Women
Clinical Oncologists 35%Biomarker Researchers 35%Patient Advocates 30%
ExplainerVaccine Tech
FDA Set to Approve First mRNA Flu Vaccine, Ushering in New Era for Seasonal Shots
Public Health & Immunology Experts 45%Vaccine Manufacturers 30%Regulatory Skeptics 25%
GLP-1 Fitness
Fitness Industry Pivots to Muscle Preservation as GLP-1 Drugs Upend Weight Loss
Fitness Industry Operators 35%Medical & Nutritional Experts 35%Public Health Advocates 30%
Deep DiveMetabolic Science
AI Discovers Naturally Occurring Peptide That Suppresses Appetite Without Ozempic's Side Effects
Metabolic Researchers 40%Clinical Endocrinologists 35%AI Drug Discovery Advocates 25%
KRAS InhibitorsClinical Trial Results
Next-Generation KRAS Inhibitor Divarasib Shows Superiority Over Approved Drugs in Head-to-Head Lung Cancer Trial
Clinical Oncologists 40%Market Analysts 30%Drug Developers 30%
InjuryNHL
Buffalo Sabres' Jiri Kulich on Track to Return Following Career-Threatening Blood Clot
Buffalo Sabres Management 40%Medical Consensus 40%Czech Hockey Community 20%
Cardiovascular Health
FDA Approves First Oral PCSK9 Inhibitor to Treat High Cholesterol
Preventive Cardiologists 40%Patient Access Advocates 30%Clinical Skeptics 30%
Heart SurgeryEvidence Pack
Sutureless, Laser-Assisted Bypass Surgery on Beating Heart Proves Safe and Effective in Landmark Trial
Cardiothoracic Surgeons 38%Medical Device Innovators 38%Health Economists 25%
ExplainerPublic Health
New UK Physical Activity Guidelines Emphasize Muscle Preservation for GLP-1 Users
Public Health Authorities 40%Clinical Researchers 35%Medical Consensus & Synthesis 25%
ExplainerAutoimmune Care
FDA Approves Groundbreaking Oral Drug for Severe Alopecia Areata, Expanding Systemic Treatments
Clinical Researchers 35%Patient Advocates 35%Healthcare Providers 30%
ExplainerMetabolic Disease
Landmark Approval: First Drug Proven to Cut Acute Pancreatitis Risk in Severe Hypertriglyceridemia
Metabolic Disease Specialists 44%Gastroenterologists 31%Regulatory & Editorial Analysts 25%
Research BriefPsychedelic Medicine
Psilocybin Completes Second Pivotal Phase 3 Trial, Paving Way for FDA Review in Depression
Clinical Researchers 41%Regulatory Pragmatists 35%Healthcare Economists 24%
ExplainerPsychiatric Medicine
First New Class of Schizophrenia Drug in Decades Targets Muscarinic Receptors, Halving Symptoms
Clinical Psychiatrists 40%Patient Advocates 35%Neuropharmacologists 25%
InjuryNHL
NHL Offseason Injury Report: Recovery Timelines Set for Connor Bedard, Seth Jarvis, and Max Domi
Medical & Management Staff 40%Roster & Cap Analysts 35%Fanbases & Local Media 25%
Medical ImagingEvidence Pack
Metamaterial MRI Antenna Delivers Sharper, Faster Scans of Brain and Eye
Imaging Physicists 40%Clinical Diagnosticians 35%Health Economics Analysts 25%
ExplainerMetabolic Science
Landmark Research: Disabling Single Protein 'Mitch' Supercharges Fat Burning and Blocks New Fat Cells
Metabolic Researchers 40%Clinical Endocrinologists 35%Pharmaceutical Developers 25%
ExplainerPsychedelic Medicine
Landmark Phase 3 Trial Finds Single-Dose Psilocybin Provides Six-Month Relief for Severe Depression
Clinical Researchers 44%Healthcare Administrators 33%Patient Advocates 22%
ExplainerPain Management
FDA Approves First-in-Class Oral Non-Opioid Drug for Acute Pain, Offering Alternative to Addictive Narcotics
Pain Medicine Specialists 35%Addiction Recovery Advocates 35%Biomedical Researchers 30%
Biotech M&A
Vertex to Acquire Crinetics Pharmaceuticals in $10 Billion All-Cash Deal to Bolster Rare Disease Pipeline
Biotech Bulls 44%Patient Advocates 39%Market Skeptics 17%
Metabolic HealthTrade-Off Analysis
Gallup Poll Finds 11% of Americans Now Take GLP-1 Drugs as Obesity Rate Declines
Public Health Optimists 45%Economic Pragmatists 30%Regulatory Cautious 25%
InjuryWTT US Smash
Liam Pitchford's Encouraging Return at US Smash Marks New Chapter After Career-Saving Hip Surgery
English Table Tennis Supporters 35%Sports Medicine Advocates 35%Neutral WTT Analysts 30%
Sleep Apnea
FDA Approves First-Ever Drug Treatment for Obstructive Sleep Apnea
Sleep Medicine Specialists 40%Patient Advocacy Groups 35%Medical Device Industry 25%
ExplainerRespiratory Health
A Single Injection Is Replacing Steroids for Severe Asthma and COPD Attacks
Respiratory Researchers 39%Patient Advocacy Groups 39%Clinical Practitioners 22%
Research BriefNeuroplasticity
Brain Activity Dictates Physical Neural Wiring, Overturning Neuroscience Dogma
Functional Neuroplasticity Advocates 45%Clinical Neurologists 30%Structural Connectomic Traditionalists 25%
Deep DiveCancer Immunotherapy
CAR T-Cell Therapy Successfully Targets Solid Tumors in Clinical Trial Breakthrough
Oncology Researchers 40%Clinical Trial Investigators 35%Public Health Experts 25%
InjuryMotoGP
Johann Zarco Avoids Reconstructive Knee Surgery, Cleared for September MotoGP Return
LCR Honda & Medical Team 40%MotoGP Paddock Analysts 35%Honda Development Program 25%
ExplainerUlcerative Colitis
Landmark Trial Finds Simple Appendectomy Significantly Reduces Relapse in Ulcerative Colitis
Medical Researchers 40%Gastroenterologists & Surgeons 35%Patient Advocates & Editorial Synthesis 25%
InjuryIFSC World Cup
Slovenia's Lučka Rakovec Completes Inspirational Return to the Wall After Thyroid Cancer Battle
Athletes in Recovery 45%Sports Media and Analysts 30%Coaching and Support Teams 25%
Research BriefGene Therapy
EC Approves First Gene Replacement Therapy for Adults and Older Children with Spinal Muscular Atrophy
Neuromuscular Specialists 39%Patient Advocacy Groups 33%Regulatory & Industry Bodies 28%
NeuroimmunologyEvidence Pack
Common Tuberculosis Vaccine Found to Remodel Brain Immunity, Offering New Clues for Alzheimer's Prevention
Neuroimmune Researchers 40%Public Health Advocates 35%Clinical Skeptics 25%
ExplainerAntibiotic Discovery
Landmark Study Finds Bacterial 'Megacluster' Producing Four Synergistic Antibiotics to Combat Drug Resistance
Evolutionary Microbiologists 35%Drug Discovery Researchers 35%Public Health Officials 30%
Per page